An investigation for investors in Alkermes Plc (NASDAQ:ALKS) shares over potential securities laws violations by Alkermes was announced and NASDAQ:ALKS stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 11/14/2017 -- Alkermes Plc is under investigation over possible securities laws violations. The investigation was announced for investors in NASDAQ:ALKS shares in connection with certain financial statements made by Alkermes Plc.
Investors who purchased shares of Alkermes Plc (NASDAQ:ALKS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm focuses on whether a series of statements by Alkermes Plc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On November 6, 2017, U.S. Senator Kamala Harris announced that she is opening an investigation into Alkermes's sales practices for its opioid-addiction treatment Vivitrol. Senator Harris specifically stated that the Company "aggressively marketed" its medication, convincing judges and prison officials to use it rather than more proven addiction-treatment products, and spent hundreds of thousands of dollars lobbying policymakers.
Those who purchased shares of Alkermes Plc (NASDAQ:ALKS) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com